The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members

While there is limited evidence for their use, over 6% of respondents stated that TH may be indicated in TRD. Due to the risk of iatrogenic thyrotoxicosis and increased morbidity the use of TH should be addressed in relevant endocrinology guidelines and consensus should be reached between specialties.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2025-09-23
DOI
https://doi.org/10.3389/fendo.2025.1665720
Citations
1
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members

Roberto Attanasio, V.Ye. Luchytskyi, Ersin Akarsu, D Niculescu et al.
1 citations
Frontiers in Endocrinology
Thyroid Disorders and Treatments
1.29
article

The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members

Roberto Attanasio, V.Ye. Luchytskyi, Ersin Akarsu, D Niculescu, Maria Alevizaki, Chagit Adler Cohen, Cătălina Poiană, В. В. Фадеев, Juan C. Galofré, Harald Dobnig, Roberto Negro, Laurence Leenhardt, Maria‐Cristina Burlacu, Petros Perros, М.D. Тronko, Marek Ruchała, Eszter Berta, Alla Shepelkevich, Anna-Maria Borissova, Stephen Ludgate, Enrico Papini, Andromachi Vryonidou, Miguel Melo, Younes Ramazan Younes, Martin Kužma, W. Edward Visser, Michal Kršek, László Hegedüs, Saara Metso, David Unuane, Anne McGowan, Francisca Marques Puga, Jacob Stampe Frølich, Tereza Planck, Mihail Boyanov, Eyal Robenshtok, Elena Yurenya, Camille Buffet, Michael Krebs, Peter Kopp, Jan Jiskra, Irfan Vardarli, Kamilla Ryom Riis, Tomasz Bednarczuk, Eric Fliers, Ivica Lazúrová, Miklós Bodor, Miloš Žarković, Juan J. Díez, Benjamin C. T. Field, Tommi Hakala, Endre Vezekenyi Nagy, Göksün Ayvaz, Carla Moran, Božidar Perić, Patrick Olivier Rosselet, Dagmar Führer‐Sakel, Tatyana Morgunova, Jamina Ćirić, Biljana Beleslin
article en
1 citations

Abstract

While there is limited evidence for their use, over 6% of respondents stated that TH may be indicated in TRD. Due to the risk of iatrogenic thyrotoxicosis and increased morbidity the use of TH should be addressed in relevant endocrinology guidelines and consensus should be reached between specialties.

Frontiers in EndocrinologyVol. 16
University College Dublin (IE), Poznan University of Medical Sciences (PL), University of Vienna (AT), Cliniques Universitaires Saint-Luc (BE), University of Debrecen (HU), Vrije Universiteit Brussel (BE), Carol Davila University of Medicine and Pharmacy (RO), Tel Aviv University (IL), Sechenov University (RU), University of Pavol Jozef Šafárik (SK), Trinity College Dublin (IE), Charles University (CZ), Heidelberg University (DE), Medical University of Warsaw (PL), Alexandrovska Hospital (BG), Rabin Medical Center (IL), Odense University Hospital (DK), East Surrey Hospital (GB), Beaumont Hospital (IE), University Hospital Heidelberg (DE), Tallaght University Hospital (IE), University of Surrey (GB), Medical University of Sofia (BG), Hospital de São João (PT), Sorbonne Université (FR), University of Belgrade (RS), Assistance Publique – Hôpitaux de Paris (FR), Hellenic Red Cross (GR), Memorial Ankara Hospital (TR), Mercy University Hospital (IE), Hospital Universitario Puerta de Hierro Majadahonda (ES), Amsterdam Neuroscience (NL), Navarre Institute of Health Research (ES), Alexandra Hospital (GR), St. Vincent's University Hospital (IE), Knappschaftskrankenhaus Recklinghausen (DE), Essen University Hospital (DE), Pitié-Salpêtrière Hospital (FR), Sisters of Charity Hospital (HR), Tampere University Hospital (FI), University Centre of Legal Medicine (CH), V.P. Komisarenko Institute of Endocrinology and Metabolism (UA), Tampere University (FI), Clinica Universidad de Navarra (ES), Skåne University Hospital (SE), Ospedale Regina Apostolorum (IT), Bone Health and Osteoporosis Foundation (US), Associazione Medici Diabetologi (IT), Instituto de Investigación Sanitaria de Santiago (ES), Ospedale Vito Fazzi (IT), University Medical Centre Mannheim (DE), Surrey and Sussex Healthcare NHS Trust (GB), General University Hospital in Prague (CZ), Groupe de recherche clinique – Tumeurs Thyroïdiennes, Belarusian State Medical University (BY), Gaziantep University (TR), University of Duisburg-Essen (DE), Universidad Autónoma de Madrid (ES), Comenius University Bratislava (SK), Medical University of Vienna (AT), University of Coimbra (PT), Newcastle University (GB), University of Amsterdam (NL), Erasmus University Rotterdam (NL), University of Lausanne (CH)
Openalex Percentile: Top 15%
Thyroid Disorders and Treatments
1.29
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.